Nemaura Medical Net Income vs. EBITDA

NMRDDelisted Stock  USD 0.93  0.01  1.06%   
Taking into consideration Nemaura Medical's profitability measurements, Nemaura Medical may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Nemaura Medical's ability to earn profits and add value for shareholders.
For Nemaura Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Nemaura Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Nemaura Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Nemaura Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Nemaura Medical over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Please note, there is a significant difference between Nemaura Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nemaura Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nemaura Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Nemaura Medical EBITDA vs. Net Income Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Nemaura Medical's current stock value. Our valuation model uses many indicators to compare Nemaura Medical value to that of its competitors to determine the firm's financial worth.
Nemaura Medical is rated below average in net income category among its peers. It is rated below average in ebitda category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nemaura Medical's earnings, one of the primary drivers of an investment's value.

Nemaura EBITDA vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Nemaura Medical

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(14.14 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Nemaura Medical

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(8.17 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Nemaura EBITDA Comparison

Nemaura Medical is currently under evaluation in ebitda category among its peers.

Nemaura Medical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Nemaura Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Nemaura Medical will eventually generate negative long term returns. The profitability progress is the general direction of Nemaura Medical's change in net profit over the period of time. It can combine multiple indicators of Nemaura Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York. Nemaura Med operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 32 people.

Nemaura Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Nemaura Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Nemaura Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Nemaura Medical's important profitability drivers and their relationship over time.

Use Nemaura Medical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nemaura Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nemaura Medical will appreciate offsetting losses from the drop in the long position's value.

Nemaura Medical Pair Trading

Nemaura Medical Pair Trading Analysis

The ability to find closely correlated positions to Nemaura Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nemaura Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nemaura Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nemaura Medical to buy it.
The correlation of Nemaura Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nemaura Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nemaura Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nemaura Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Nemaura Medical position

In addition to having Nemaura Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Financials Thematic Idea Now

Financials
Financials Theme
Companies that provide financial services to business or retail customers. The Financials theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Consideration for investing in Nemaura Pink Sheet

If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing